Table 3: Pretreatment sputum smear grade and treatment outcome among clients.

Pretreatment sputum smear grade (%)Total
NegativeScanty (sc) (1+) (2+) (3+)

Age range (years)
 <102 (0.9)2
 10–194 (1.9)1 (0.5)2 (0.9)1 (0.5)3 (1.4)11
 20–299 (4.2)2 (0.9)4 (1.9)8 (3.8)12 (5.6)35
 30–3917 (8.0)4 (1.9)3 (1.4)10 (4.7)10 (4.7)44
 40–4916 (7.5)4 (1.9)13 (6.1)4 (1.9)14 (6.6)51
 50–5917 (8.0)5 (2.3)6 (2.8)4 (1.9)8 (3.8)40
 ≥6022 (10.3)2 (0.9)6 (2.8)30
 Total87 (40.8)16 (7.5)28 (13.1)29 (13.6)53 (24.9)213
Sex
 Female25 (11.7)6 (2.8)4 (1.9)7 (3.3)12 (5.6)54
 Male62 (29.1)10 (4.7)24 (11.3)22 (10.3)41 (19.2)159
 Total87 (40.8)16 (7.5)28 (13.1)29 (13.6)53 (24.9)213
Treatment outcome
 Cured13 (6.1)25 (11.7)27 (12.7)45 (21.1)110 (51.6)
 Completed80 (37.6)80 (37.6)
 Treatment failure1 (0.5)2 (0.9)3 (1.4)
 Lost to follow-up1 (0.5)1 (0.5)2 (0.9)
 Died at home6 (2.8)2 (0.9)1 (0.5)1 (0.5)7 (3.3)17 (8.0)
 Died at Chest Ward1 (0.5)1 (0.5)
 Total87 (40.8)16 (7.5)28 (13.1)29 (13.6)53 (24.9)213

Negative: no Acid-Fast Bacilli (AFB) seen in at least 100 fields; scanty (sc): 1–9 AFB found in 100 fields; (1+): 10–99 AFB found in 100 fields; (2+): 1–10 AFB found per field in at least 50 fields; (3+): more than 10 AFB per field in at least 20 fields.